Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Humacyte, Inc. (HUMA) had Revenue of $0.52M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$0.52M
Net Income	$39.14M
Cost of Goods Sold	$0.15M
Gross Profit	$0.37M
Operating Expenses	$23.70M
Operating Income	$-23.18M
Non-Operating Income/Expense	$62.32M
Pre-Tax Income	$39.14M
Normalized Pre-Tax Income	$39.14M
Income after Taxes	$39.14M
Income from Continuous Operations	$39.14M
Consolidated Net Income/Loss	$39.14M
Normalized Income after Taxes	$39.14M
EBIT	$-23.18M
EBITDA	$-21.35M
Weighted-Average Shares Outstanding (Basic)	131.50M
Weighted-Average Shares Outstanding (Diluted)	131.76M
Earnings per Share (EPS) (Basic)	$0.28
Earnings per Share (EPS) (Diluted)	$0.28
Balance Sheet Financials
Current Assets	$73.70M
Property, Plant, and Equipment	$22.44M
Long-Term Assets	$88.85M
Total Assets	$162.55M
Current Liabilities	$20.03M
Long-Term Debt	$12.84M
Long-Term Liabilities	$106.48M
Total Liabilities	$126.51M
Common Equity	$36.04M
Tangible Shareholders Equity	$36.04M
Shareholders Equity	$36.04M
Common Shares Outstanding	155.12M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-28.60M
Cash Flow from Investing Activities	$-0.23M
Cash Flow from Financial Activities	$46.74M
Beginning Cash	$95.29M
End Cash	$113.20M
Increase/Decrease in Cash	$17.91M
Stock-Based Compensation	$2.49M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.68
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.44
Gross Margin	71.57%
Operating Margin	-4484.33%
EBIT Margin	-4484.33%
EBITDA Margin	--
Pre-Tax Profit Margin	7570.41%
Profit Margin	7570.41%
Free Cash Flow	$-28.83M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.00
Inventory Turnover	0.02
Receiveable Turnover	1.06
Days Sales in Receivables	84.95
Return on Equity	108.59%
Return on Tangible Equity	108.59%
Return on Assets	24.08%
Return on Investments	80.06%
Book Value Per Share	$0.23
Free Cash Flow per Share	$-0.22
Operating Cash Flow per Share	$-0.22

Data from Zacks Investment Research, Inc.